Ventaris develops investigational medical devices intended for surgical applications. These products are currently limited to investigational use only and are not approved or cleared by the FDA or other regulatory bodies for commercial sale. The company focuses on creating new technologies for the medical device market.
Funding
Funding not disclosed
Founders
Product
Problem
Current surgical procedures, particularly those employing minimally invasive techniques, often face challenges in achieving optimal dexterity and tactile feedback for surgeons. This can lead to extended operative times and potential complications, impacting both patient recovery and procedural efficiency.
Solution
Ventaris Surgical develops advanced robotic surgical instruments engineered to augment surgeon capabilities during complex procedures. Our instruments provide enhanced articulation and haptic feedback, allowing for greater precision and control in confined anatomical spaces. By integrating sophisticated electromechanical actuators and proprietary sensor arrays, our technology aims to reduce surgeon fatigue and improve the fidelity of instrument manipulation. This facilitates more efficient tissue manipulation and dissection, ultimately contributing to improved patient outcomes and shorter recovery periods.
Target Audience
Our primary customers are surgeons specializing in minimally invasive procedures, as well as hospitals and surgical centers seeking to upgrade their robotic surgery capabilities.
Features
- Articulated instrument tips with a wide range of motion for enhanced maneuverability
- Integrated force-feedback sensors to provide surgeons with tactile information during tissue interaction
- Modular design for compatibility with various robotic surgical platforms
- Sterilizable and reusable instrument components to optimize cost-effectiveness
- Precision-machined components for high-durability and consistent performance
- Ergonomically designed instrument handles for improved surgeon comfort and control